2017
DOI: 10.1016/j.ijoa.2017.06.001
|View full text |Cite
|
Sign up to set email alerts
|

The role of carbetocin in the prevention and management of postpartum haemorrhage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 6 publications
0
3
0
Order By: Relevance
“…Most post-partum hemorrhage is due to an atonic uterus. Use of uterotonics such as misoprostol or oxytocin, and perhaps carbetocin, a log-acting and heat stable oxytocin substitute, given immediately after delivery can prevent many of the post-partum hemorrhages associated with an atonic uterus [ 41 ]. However, major reductions in mortality from hemorrhage usually occur with appropriate treatment of hemorrhage once it occurs.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Most post-partum hemorrhage is due to an atonic uterus. Use of uterotonics such as misoprostol or oxytocin, and perhaps carbetocin, a log-acting and heat stable oxytocin substitute, given immediately after delivery can prevent many of the post-partum hemorrhages associated with an atonic uterus [ 41 ]. However, major reductions in mortality from hemorrhage usually occur with appropriate treatment of hemorrhage once it occurs.…”
Section: Introductionmentioning
confidence: 99%
“…Infection is the generally considered the second most common cause of maternal death [ 10 ]. The most important causes of infection-related maternal mortality are the bacterial infections of the uterus and related sepsis [ 41 ]. The reasons for the high risk of infection post-partum are not hard to understand.…”
Section: Introductionmentioning
confidence: 99%
“…Carbetocin is a potent and selective oxytocin receptor agonist, which is brain permeant and shows a longer elimination half-life than oxytocin (Dvorská et al, 1992). This drug is currently marketed in different countries for the treatment of postpartum bleeding in humans (Chen et al, 2016;Engstrøm et al, 1998;Meshykhi et al, 2016;Onwochei and Monks, 2017;Van der Nelson et al, 2017). Carbetocin is a synthetic peptide that shows no oral bioavailability and therefore cannot be transferred from lactating dams to pups through the milk (Silcox et al, 1993).…”
Section: Introductionmentioning
confidence: 99%